Literature DB >> 10871053

Isolation of a proteinase with plasminogen-activating activity from Lachesis muta muta (bushmaster) snake venom.

E F Sanchez1, C I Santos, A Magalhaes, C R Diniz, S Figueiredo, J Gilroy, M Richardson.   

Abstract

A plasminogen activator enzyme (LV-PA) from Lachesis muta muta venom was purified to homogeneity using gel filtration and anion exchange chromatography. SDS-PAGE under reducing conditions showed a single protein band with an Mr of 33,000 Da. It is an acidic glycoprotein which activates plasminogen to plasmin indirectly, functioning via prior formation of a molecular complex, known as plasminogen activator. The purified preparation catalyzes the hydrolysis of several p-nitroanilide peptide substrates containing Lys at the scissile bond. In contrast, no hydrolysis was detected on the synthetic substrates TAME and BAPNA, which contain arginine. By the use of the plasmin-specific chromogenic substrate Tos-Gly-Pro-Lys-pNA, the preparation had a plasmin-like activity of 0.68 U/mg, which was 35.8-fold higher than that of the crude venom from which it was prepared. In vitro, fibrin hydrolysis using LV-PA as plasminogen activator displayed more similarity with the effect produced by streptokinase (SK). SDS-PAGE (10%) analysis showed a 115-kDa complex formation after incubation of plasminogen with either LV-PA or SK. At a molar ratio of 50:1 (fibrinogen:enzyme), the preparation exhibited weakly fibrinogenolytic activity. However, LV-PA is distinguished from thrombin in that it does not clot fibrinogen. After incubation of LV-PA with platelet-rich plasma, the enzyme (2 microM) showed no effect on platelet aggregation induced by ADP, epinephrine, or collagen. Comparison of the N-terminal sequence of LV-PA with other snake venom plasminogen activators revealed that LV-PA exhibits a high degree of sequence identity with the TsVPA from Trimeresurus stejnegeri (90%) and with the Haly-PA from Agkistrodon halys (85%). LV-PA also has homology with other snake venom serine proteinases such as the thrombin-like/gyroxin analogue (38%) from bushmaster venom and with other coagulation serine proteases. The proteinase was readily inhibited by treatment with p-nitrophenyl p-guanidinebenzoate, p-aminobenzamidine, and phenylmethanesulfonyl fluoride but was not affected by metal chelators.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871053     DOI: 10.1006/abbi.2000.1781

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  The evolution of recombinant thrombolytics: Current status and future directions.

Authors:  Yogender Pal Khasa
Journal:  Bioengineered       Date:  2016-10-03       Impact factor: 3.269

Review 2.  Structures and Functions of Snake Venom Metalloproteinases (SVMP) from Protobothrops venom Collected in Japan.

Authors:  Etsuko Oyama; Hidenobu Takahashi
Journal:  Molecules       Date:  2017-08-04       Impact factor: 4.411

3.  Liquid chromatographic nanofractionation with parallel mass spectrometric detection for the screening of plasmin inhibitors and (metallo)proteinases in snake venoms.

Authors:  Barbara M Zietek; Morwarid Mayar; Julien Slagboom; Ben Bruyneel; Freek J Vonk; Govert W Somsen; Nicholas R Casewell; Jeroen Kool
Journal:  Anal Bioanal Chem       Date:  2018-08-09       Impact factor: 4.142

4.  Subproteome of Lachesis muta rhombeata venom and preliminary studies on LmrSP-4, a novel snake venom serine proteinase.

Authors:  Gisele A Wiezel; Karla Cf Bordon; Ronivaldo R Silva; Mário Sr Gomes; Hamilton Cabral; Veridiana M Rodrigues; Beatrix Ueberheide; Eliane C Arantes
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2019-04-15

Review 5.  The Urgent Need to Develop Novel Strategies for the Diagnosis and Treatment of Snakebites.

Authors:  Harry F Williams; Harry J Layfield; Thomas Vallance; Ketan Patel; Andrew B Bicknell; Steven A Trim; Sakthivel Vaiyapuri
Journal:  Toxins (Basel)       Date:  2019-06-20       Impact factor: 4.546

6.  Atroxlysin-III, A Metalloproteinase from the Venom of the Peruvian Pit Viper Snake Bothrops atrox (Jergón) Induces Glycoprotein VI Shedding and Impairs Platelet Function.

Authors:  Luciana S Oliveira; Maria Inácia Estevão-Costa; Valéria G Alvarenga; Dan E Vivas-Ruiz; Armando Yarleque; Augusto Martins Lima; Ana Cavaco; Johannes A Eble; Eladio F Sanchez
Journal:  Molecules       Date:  2019-09-26       Impact factor: 4.411

7.  Solenodon genome reveals convergent evolution of venom in eulipotyphlan mammals.

Authors:  Nicholas R Casewell; Daniel Petras; Daren C Card; Vivek Suranse; Alexis M Mychajliw; David Richards; Ivan Koludarov; Laura-Oana Albulescu; Julien Slagboom; Benjamin-Florian Hempel; Neville M Ngum; Rosalind J Kennerley; Jorge L Brocca; Gareth Whiteley; Robert A Harrison; Fiona M S Bolton; Jordan Debono; Freek J Vonk; Jessica Alföldi; Jeremy Johnson; Elinor K Karlsson; Kerstin Lindblad-Toh; Ian R Mellor; Roderich D Süssmuth; Bryan G Fry; Sanjaya Kuruppu; Wayne C Hodgson; Jeroen Kool; Todd A Castoe; Ian Barnes; Kartik Sunagar; Eivind A B Undheim; Samuel T Turvey
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-26       Impact factor: 11.205

8.  Data for a direct fibrinolytic metalloproteinase, barnettlysin-I from Bothrops barnetti (barnett(,)s pitviper) snake venom with anti-thrombotic effect.

Authors:  Eladio Flores Sanchez; Michael Richardson; Luiza Helena Gremski; Silvio Sanches Veiga; Armando Yarleque; Stephan Niland; Augusto Martins Lima; Maria Inácia Estevao-Costa; Johannes Andreas Eble
Journal:  Data Brief       Date:  2016-04-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.